Last edition
News about "cancer therapy "
Xspray Pharma Licenses Dasatinib Patents to Handa Therapeutics for US and Asian Markets
Xspray Pharma has entered into a license agreement with Handa Therapeutics, granting Handa a non-exclusive license to certain Xspray patents.
Cancer Therapy | 14/08/2025 | By Dineshwori
Glenmark's IGI Signs Licensing Deal with AbbVie for Investigational Cancer Therapy
AbbVie to lead global development, manufacturing and commercialisation of Ichnos Glenmark Innovation’s (IGI) investigational cancer therapy ISB 2001 in North America, Europe, Japan, and Greater China, while Glenmark will take these roles in emerging markets.
Cancer Therapy | 11/07/2025 | By Dineshwori | 108
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy